Annual Reports

Metrion Biosciences Directors’ Report and Financial Statements for the Period Ended 31st December 2023

Revenues continued to grow in 2023 with an increase of 14.2% on last year and a strong performance given the widely reported slow-down in the overall pharma outsourced services market in 2023.
Download

Metrion Biosciences Directors’ Report and Financial Statements for the Period Ended 31st December 2022

2022 was another year of successful growth for the Company. Both customer numbers and revenue per customer increased in 2022 compared to 2021 and almost 50% of 2022 fee-for-service work was for customers based in the USA.
Download

Metrion Biosciences Directors’ Report and Financial Statements for the Period Ended 31st December 2021

The search for breakthroughs in medicine and discovery of new cures for disease continues to fuel the growth of the worldwide bioscience industry, with ion channel biology one of several fast-growing areas of innovation in drug discovery
Download

Metrion Biosciences Directors’ Report and Financial Statements for the Period Ended 31st December 2020

As drug discovery research becomes ever more sophisticated, the emergence of ion channel proteins as novel targets for drug action and/or the source of unwanted toxicity has meant there is a rapidly growing demand for electrophysiology assays and other ion channel services and expertise.
Download

Metrion Biosciences Directors’ Report and Financial Statements for the Period Ended 31st December 2019

Metrion Biosciences’ growing reputation is reflected in the rapid growth of revenues, which in 2019 increased by 67% over 2018 to a full year total of £2.53m. At the same time, the Company has significantly expanded the geographic diversity of its customers and is today regularly undertaking work for clients in the UK, Europe, the USA and Japan.
Download

Metrion Biosciences Directors’ Report and Financial Statements for the Period Ended 31st December 2018

Download

Metrion Biosciences Directors’ Report and Financial Statements for the Period Ended 31st December 2017

Download

Metrion Biosciences Directors’ Report and Financial Statements for the Period Ended 31st December 2016

Download
Metrion Biosciences

Let’s work together

If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.
Contact us for a quote or discussion
Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
Copyright © 2024 Metrion. All rights reserved | Privacy notice | Registered as a company in England and Wales: 09669815 | VAT: GB 219828479
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram